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Objective. Previous studies of skeletal remains
have suggested that both enthesophytes and osteophytes
are manifestations of an underlying bone-forming ten-
dency. A greater prevalence of osteophytes has been
observed among individuals with high bone mass
(HBM) compared with controls. This study was under-
taken to examine the possible interrelationships be-
tween bone mass, enthesophytes, and osteophytes in a
population of individuals with extreme HBM.
Methods. Cases of HBM (defined according to
bone mineral density [BMD] Z scores on dual x-ray
absorptiometry) from the UK-based HBM study were
compared with a control group comprising unaffected
family members and general population controls from
the Chingford and Hertfordshire cohort studies. Pelvic
radiographs from cases and controls were pooled and
evaluated, in a blinded manner, by a single observer,
who performed semiquantitative grading of the radio-
graphs for the presence and severity of osteophytes and
enthesophytes (score range 0–3 for each). Logistic re-
gression analysis was used to identify significant asso-
ciations, with a priori adjustment for age, sex, and body
mass index.
Results. In this study, 226 radiographs from
HBM cases and 437 radiographs from control subjects
were included. Enthesophytes (grade >1) and moderate
enthesophytes (grade >2) were more prevalent in HBM
cases compared with controls (adjusted odds ratio [OR]
3.00 [95% confidence interval (95% CI) 1.96–4.58], P <
0.001 for any enthesophyte; adjusted OR 4.33 [95% CI
2.67–7.02], P < 0.001 for moderate enthesophytes). In
the combined population of cases and controls, the
enthesophyte grade was positively associated with BMD
at both the total hip and lumbar spine (adjusted P for
trend < 0.001). In addition, a positive association
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between osteophytes and enthesophytes was observed;
for each unit increase in enthesophyte grade, the odds of
any osteophyte being present were increased >2-fold
(P < 0.001).
Conclusion. Strong interrelationships were ob-
served between osteophytes, enthesophytes, and HBM,
which may be helpful in defining a distinct subset of
patients with osteoarthritis characterized by excess
bone formation.
The term “enthesis” describes the site of inser-
tion of a tendon, ligament, fascia, or articular capsule
into bone (1,2). An enthesophyte is a bony spur arising
at an enthesis, extending in the direction of pull of the
ligament or tendon (3). Several conditions are associ-
ated with the formation of enthesophytes, including the
seronegative spondyloarthritides, various endocrine dis-
orders such as diabetes mellitus, local trauma, and
calcium pyrophosphate deposition disease (1,4). How-
ever, enthesophytes may also be degenerative in nature
(1) or may have no clear underlying cause (3,5).
Enthesophytes are a feature of diffuse idiopathic
skeletal hyperostosis (DISH), a condition in which the
presence of osteophytes around large joints has also
been noted (1). This has led to speculation that the
formation of osteophytes and enthesophytes may be
manifestations of a common underlying process. In
support of this concept, archaeologic studies involving
direct examination of skeletons have revealed strong
positive correlations between the presence of entheso-
phytes and the presence of osteophytes (3,6). Further-
more, in one study, an association between generalized
enthesophyte formation and bony eburnation (sclerosis
of bony surfaces thought to represent full-thickness
cartilage loss) was seen (6), leading to the suggestion
that osteoarthritis (OA) may represent a systemic disor-
der of bone in which the bony response to mechanical
stress is abnormal. However, only a few studies have
used joint imaging to examine the relationships between
enthesophytes and osteophytes/OA, and conclusions
have been inconsistent (7–9).
In contrast, an association between increased
bone mineral density (BMD) and radiographic OA has
been widely reported (10–12), and this association ap-
pears to be strongest with the bony features of OA, such
as osteophytes (13). We recently carried out a study of
radiographic hip OA in a population of individuals with
high bone mass (HBM). In comparison with control
subjects, HBM cases had an increased prevalence of
OA, predominantly characterized by the presence of
osteophytes and subchondral sclerosis, suggesting a pro-
pensity to form bone (14). Moreover, previous clinical
phenotyping of these individuals showed that those with
HBM more frequently had misshapen or extra bone,
including at the tendon and ligament insertions, com-
pared with a control population (15). This led us to
speculate that enthesophytes may also form part of the
HBM phenotype.
The aim of this study was to investigate the
relationship between HBM and the presence of entheso-
phytes on pelvic radiographs. Specifically, we aimed to
determine 1) whether HBM has an association with
enthesophytes similar to that previously observed with
osteophytes, and 2) whether osteophytes and entheso-
phytes are themselves associated within this population,
and whether any observed relationship varies according
to the presence or absence of HBM. We hypothesized
that radiographic enthesophytes would be more preva-
lent in HBM cases, possibly reflecting a tendency to
form excess bone, and that the presence and severity of
osteophytes and enthesophytes would also be strongly
associated.
SUBJECTS AND METHODS
HBM study population. The HBM study is a UK-
based, multicenter observational study of adults with unex-
plained HBM, as fully described elsewhere (15). Briefly, 13
dual x-ray absorptiometry (DXA) databases in the UK were
screened for T scores and/or Z scores for BMD greater than or
equal to 4. All of the DXA images were inspected by trained
clinicians for artefactual causes of elevated BMD on DXA;
49.4% of the scans were excluded because their high T scores
and/or Z scores reflected degenerative disease/OA/scoliosis,
and a further 15.5% of the scans were excluded for other
reasons, including surgical/malignant/Pagetic artefacts (15).
The definition of an HBM index case was refined to require
either of the following criteria: 1) a Z score greater than or
equal to 3.2 at the L1 vertebra of the lumbar spine plus a
Z score greater than or equal to 1.2 at the total hip or 2) a Z
score greater than or equal to 3.2 at the total hip plus
a Z score greater than or equal to 1.2 at the L1 vertebra of
the lumbar spine. Misclassification of HBM case status was
minimized by using the Z score at L1, which, in contrast to the
values in the lower lumbar spine, was previously found to be
unassociated with lumbar spine OA as assessed on DXA
images in a subgroup of HBM cases (15,16).
Index cases with unexplained HBM were recruited,
and relatives and spouses of these individuals were invited to
undergo DXA screening. Among first-degree relatives, HBM
has been defined as a summed L1 Z score plus total hip Z
score of greater than or equal to 3.2 (15). Applying this
definition of HBM, 41% of the relatives screened were found
to be affected, and were combined with the HBM index cases
to form the HBM group. The remaining, unaffected first-
degree relatives/spouses formed the family control group (15).
Cases and controls underwent identical assessments,
including a structured interview and clinical examination.
Anteroposterior (AP) pelvic radiographs and AP/lateral lum-
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bar spine radiographs were obtained from participants ages
40 years. Written informed consent was obtained from all
participants, consistent with the Declaration of Helsinki (17),
and the study was approved by the Bath multicenter Research
Ethics Committee (REC) and each National Health Service
local REC. For this study, HBM cases were then divided into
5-year age bands by sex, prior to selection of additional
controls by age- and sex-stratified random sampling from 2
population-based cohorts.
General population controls. Chingford 1,000 Women
Study controls. The Chingford 1,000 Women Study started in
1989 with an initial recruitment of 1,003 women ages 45–64
years from the age/sex register of a general practice in Ching-
ford, North-East London (10); of these women, 470 (46.9%)
had a radiographic followup evaluation at 20 years. Supine
pelvic radiographs were obtained in followup years 2, 8, and
20; radiographs from year 20 were digital and those from years
2 and 8 were latterly digitized. Controls from the Chingford
cohort were randomly selected in a 2:1 ratio of controls to
female HBM cases within each age band, except the lower age
band (ages 40–49 years) and upper age band (80 years), for
which a control-to-case ratio of 3:1 was used. A single radio-
graph per participant was included; controls in the upper age
bands were selected first, to ensure sufficient numbers of
available radiographs.
Hertfordshire Cohort Study (HCS) controls. For the
HCS cohort, 3,000 men and women born in Hertfordshire
between 1931 and 1939 and still resident there in 1998–2003
were recruited (18). Recently, a subset of HCS participants
were recruited into the European Project on Osteoarthritis
(EPOSA) (19). As part of the EPOSA study, supine pelvic
and/or knee radiographs were obtained from 207 men and 203
women (ages 71.5–80.6 years at the time of radiographic
evaluation); these individuals formed the selection pool for the
present study. The HCS EPOSA study controls were selected
in a 2:1 ratio with HBM cases within each appropriate age
band (ages 70–74 years, 75–79 years, and 80 years).
Assessment of radiographs. Osteophytes. All case and
control radiographs were pooled for assessment, with the files
presented in a blinded random order. Radiographs were
graded by a single observer (SAH) following focused radio-
logic training. Using an established atlas (20), the presence of
osteophytes at each location within the hip joint (superior
acetabular, medial femoral, and lateral femoral) was scored on
a scale of 0–3. These scores were used to generate binary
variables for the presence of any osteophyte (defined as any
osteophyte score of 1), presence of moderate osteophyte
(defined as any osteophyte score of 2), and presence of
femoral osteophyte (defined as an osteophyte score of 1 in
the medial or lateral femoral location) affecting either hip on
each radiograph. Categorical variables for the maximum os-
teophyte grade per pelvis (scale 0–3), total number of osteo-
phyte sites per pelvis (scale 0–6), and total osteophyte score
per pelvis (scale 0–18) were also generated, with the latter
score being obtained by summing all of the osteophyte grades
at the 6 possible sites on each radiograph. The presence or
absence of chondrocalcinosis was also noted (scale 0–1).
At the end of the study, 60 randomly selected radio-
graphs were regraded by the primary observer and a second
experienced observer (PD) to establish intra- and interrater
reproducibility. Intrarater kappa values for the binary osteo-
phyte variables at each hip joint were 0.73 for the presence of
any osteophyte and 0.74 for moderate osteophyte, representing
good intrarater agreement. However, interrater kappa values
were substantially poorer, being 0.19 for the presence of any
osteophyte and 0.33 for moderate osteophyte; this was mainly
due to poor reproducibility of the scores for superior acetab-
ular osteophytes between the 2 observers (as has been noted by
other investigators [20]). Therefore, femoral osteophytes have
been reported separately (interrater kappa value for the
presence of binary femoral osteophyte 0.63).
Enthesophytes. Enthesophytes were graded as 0 for
absent, 1 for mild, 2 for moderate, or 3 for florid, based on the
assessor’s overall assessment of the entire radiograph, paying
particular attention to the iliac crests, greater and lesser
trochanters, and ischial tuberosities. To improve standardiza-
tion, a consensus meeting was held prior to commencement of
the study, in which 2–3 examples of each grade were identified
and used to compile an atlas, which was then made available
for reference. Atlas examples were selected from all of the
pooled radiographs, following blinding of the case/control
status. Examples of pelvic radiographs showing each entheso-
phyte grade are presented in Figure 1.
During the grading of enthesophytes, the assessor
noted if the radiographic image was incomplete (missing2 of
the above-described sites), which would preclude accurate
Figure 1. Pelvic radiographs obtained from our enthesophyte atlas, showing examples of mild enthesophytes (grade 1), characterized by subtle new
bone formation at the anterior superior iliac spine (ASIS) and greater trochanter (vertical arrows) (A), moderate enthesophytes (grade 2),
characterized by new bone formation mainly at the ASIS and greater trochanter (B), and florid enthesophytes (grade 3), characterized by marked
new bone formation around the ASIS, iliac crests, greater and lesser trochanters, and, to a lesser extent, the ischial tuberosity (C). Horizontal arrows
indicate the presence of osteophytes at the superior acetabular margin in A–C and at the left medial femur in C. Example images were made available
as full-screen digital images to readers during scoring.
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assessment; these radiographs were later excluded. The cate-
gorical enthesophyte grading (scale 0–3) was used to generate
2 binary variables for analysis: presence of any enthesophyte
(grade 1) and presence of moderate enthesophytes (grade
2). Weighted intrarater and interrater kappa values for the
categorical enthesophyte grade were 0.88 and 0.62, respec-
tively, and intrarater and interrater kappa values for the binary
variables were 0.80 and 0.55, respectively, for any enthesophyte
and 0.92 and 0.50, respectively, for moderate enthesophytes.
Assessment of covariates. Values for age (at the time
of radiographic evaluations), sex, body mass index (BMI), and
DXA-assessed BMD were obtained from the data sets of each
study for use in the present analysis. BMI was calculated as
weight (in kg) divided by height (in square meters), using the
measurements obtained closest to the time of radiographic
evaluation. Data on relevant self-reported medical conditions
were available for the HBM study cases and controls, as were
basic biochemical measures, including the levels of serum
alkaline phosphatase and phosphate.
Statistical analysis. Demographic statistics for the
different study populations are summarized as the mean  SD
for continuous variables and counts (percentages) for categor-
ical variables. In this case–control analysis, categorical vari-
ables were initially cross-tabulated, and percentages were
calculated. The chi-square test was used to assess associations
between binary variables. Logistic regression was used to
examine associations between the exposure (HBM case status)
and the binary enthesophyte/osteophyte outcome variables,
with adjustment for a priori confounders (age, sex, and BMI).
The odds ratios (ORs) with 95% confidence intervals (95%
CIs) before and after adjustments are presented. Planned
sensitivity analyses included 1) analyses that excluded HBM
cases with any condition known to be associated with entheso-
phyte formation (1) or HBM cases with low serum alkaline
phosphatase/phosphate levels, and 2) analyses that excluded
HBM cases and family controls with evidence of possible
DISH affecting the lumbar spine. Logistic regression was then
used to examine associations between categorical
enthesophyte/osteophyte grade and binary osteophyte/
enthesophyte outcomes, with adjustment for confounders and
stratification by HBM case status. Data were analyzed using
Stata statistical software (release 12; StataCorp).
RESULTS
Selection and characteristics of the participants.
Figure 2 summarizes the selection of radiographs for
inclusion. Those radiographs judged to be of unaccept-
Figure 2. Selection of radiographs from high bone mass (HBM) cases (index plus affected relatives) and unaffected family controls (see ref. 15 for
a full description of the process of study recruitment) (A), radiographs from female control subjects in the Chingford 1,000 Women Study (B), and
radiographs from male and female control subjects in the European Project on Osteoarthritis (EPOSA) substudy of the Hertfordshire Cohort Study
(HCS) (C). 1Reason recorded for missing radiograph in HBM cases: unable to travel (n  7), no radiographs at study center (n  23), unable to
attend/wait/comply (n 4), patient declined (n 8), not done (reason unknown) (n 9), resides abroad (n 2), or bilateral hip replacements (n
6). 2Reason recorded for missing radiograph in family controls: did not continue in study (n  1), unable to travel (n  1), no radiographs at study
center (n  9), unable to attend/wait/comply (n  2), subject declined (n  4), not done (reason unknown) (n  3), or bilateral hip replacements
(n  1). 3Sampling frame constructed from dates of the followup visits at years 2, 8, and 20. 4Reason recorded for missing radiograph in the
Chingford Study controls: not found at time of request (n  6), not digitized (n  18), or unknown reason (n  15). 5Sampling frame constructed
from the EPOSA study radiograph appointment dates. 6Reason recorded for missing radiograph in the HCS EPOSA controls: unilateral hip
radiograph only (n  1), bilateral hip replacements (n  3), or unknown (n  7). 7Incomplete radiographs were defined as those missing 2 pelvic
ligament insertion sites. THR  total hip replacement.
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able quality (1 case radiograph and 18 control radio-
graphs) and those with missing osteophyte data (13 case
radiographs and 32 control radiographs, including total
hip replacement) were excluded from the outset. Incom-
plete radiographs were also excluded, particularly affect-
ing earlier digitized radiographs from the Chingford
cohort, in which the iliac crests were frequently not
visible. In total, 226 HBM case radiographs and 437
control radiographs were included in the analysis.
Characteristics of the study population are shown
in Table 1. Controls tended to be older than cases (mean
age 68.1 years versus 62.5 years). Cases had a higher
mean BMI compared with controls (30.3 kg/m2 versus
27.7 kg/m2). Moreover, as expected, cases had higher
BMD at both the total hip and the L1 vertebra. The
BMD variables were approximately normally distrib-
uted, apart from 1 individual considered to be an
extreme HBM outlier, with a total hip BMD of 2.47
gm/cm2. The proportion of women was approximately
equal between the groups (76.6% of cases versus 78.5%
of controls). Compared with the control subjects who
were included, control subjects who were excluded (due
to having incomplete radiographs) were younger, had a
lower BMI, and were more often female (results not
shown). The prevalence of enthesophytes and osteo-
phytes was greater among cases compared with controls
regardless of the binary cutoff chosen (Table 1).
Enthesophytes and osteophytes in HBM cases
compared with controls. Regression analyses. Unadjusted
regression analyses revealed an increased odds of the
presence of any enthesophyte (OR 2.23 [95% CI 1.56–
3.18], P  0.001) and moderate enthesophytes (OR 3.59
[95% CI 2.36–5.48], P 0.001) in HBM cases compared
with controls (Table 2). Similarly, the odds of any
osteophyte being present (OR 1.59 [95% CI 1.07–2.38],
P 0.023), any moderate osteophyte being present (OR
2.02 [95% CI [1.39–2.94], P  0.001), and any femoral
osteophyte being present (OR 1.38 [95% CI 0.96–1.99],
Table 1. Descriptive characteristics of the study population
Controls
HBM cases
(n  226)
Family controls
(n  124)
Chingford controls
(n  193)
Hertfordshire controls
(n  120)
All controls
(n  437)
Age, mean  SD years 62.5 11.4 59.3  12.9 69.4 9.1 75.1  2.7 68.1  11.0
BMI, mean  SD kg/m2* 30.3  5.7 27.8  4.7 27.8  4.7 27.5  3.9 27.7 4.5
BMD, mean  SD gm/cm2†
Total hip 1.25 0.17 0.97  0.13 0.91 0.12 0.94  0.13 0.93  0.13
L1 vertebra 1.40  0.17 1.05 0.16 0.89  0.15 0.95  0.19 0.95 0.18
Female, no. (%) 173 (76.6) 60 (48.4) 193 (100.0) 90 (75.0) 343 (78.5)
Any enthesophytes, no. (%) 170 (75.2) 62 (50.0) 107 (55.4) 83 (69.2) 252 (57.7)
Moderate enthesophytes (grade 2),
no. (%)
66 (29.2) 9 (7.3) 19 (9.8) 17 (14.2) 45 (10.3)
Any osteophyte, no. (%) 185 (81.9) 82 (66.1) 149 (77.2) 92 (76.7) 323 (73.9)
Moderate osteophyte (grade 2),
no. (%)
69 (30.5) 18 (14.5) 37 (19.2) 23 (19.2) 78 (17.9)
Femoral osteophyte, no. (%) 65 (28.8) 21 (16.9) 44 (22.8) 34 (28.3) 99 (22.7)
* BMI  body mass index.
† Bone mineral density (BMD) variables were standardized according to the scanner type (Hologic for the Chingford and
Hertfordshire study controls, mixed Lunar/Hologic for the high bone mass [HBM] cases and family controls depending on study
center) using standard equations (see refs. 48 and 49). When the BMD values for both the right hip and the left hip were
available (n  73), the mean value was used. Sample sizes (no. of individuals or pelvises) for all variables are as shown, except for
total hip BMD (n 218 HBM cases, n 123 family controls, n  180 Chingford controls, and n  120 Hertfordshire controls)
and L1 BMD (n  217 HBM cases, n  123 family controls, n  183 Chingford controls, and n  120 Hertfordshire controls).
Table 2. Regression analysis of enthesophyte and osteophyte vari-
ables in HBM cases compared with all pooled controls*
Outcome
OR (95% CI),
HBM cases vs. controls P
Any enthesophyte
Unadjusted model 2.23 (1.56–3.18) 0.001
Adjusted model 3.00 (1.96–4.58) 0.001
Moderate enthesophytes
Unadjusted model 3.59 (2.36–5.48) 0.001
Adjusted model 4.33 (2.67–7.02) 0.001
Any osteophyte
Unadjusted model 1.59 (1.07–2.38) 0.023
Adjusted model 2.24 (1.44–3.49) 0.001
Moderate osteophyte
Unadjusted model 2.02 (1.39–2.94) 0.001
Adjusted model 2.32 (1.55–3.49) 0.001
Any femoral osteophyte
Unadjusted model 1.38 (0.96–1.99) 0.085
Adjusted model 1.67 (1.13–2.47) 0.011
* Osteophyte variables refer to the worse hip per pelvis. Values are the
odds ratio (OR) with 95% confidence interval (95% CI) for each
outcome in 226 high bone mass (HBM) cases and 437 pooled controls,
in unadjusted regression analyses and in analyses adjusted for age, sex,
and body mass index.
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P  0.085) were all increased in HBM cases compared
with controls.
The presence of enthesophytes was positively
associated with increasing age and male sex (results not
shown). A positive association between enthesophytes
and BMI was also observed. Therefore, regression ana-
lyses were rerun with adjustments for age, sex, and BMI,
all of which strengthened the above-noted associations.
The adjusted OR for any enthesophyte in HBM cases
was 3.00 (95% CI 1.96–4.58; P  0.001) (Table 2),
representing a 3-fold increased prevalence of entheso-
phytes in HBM cases compared with controls. Similarly,
the adjusted OR for moderate enthesophytes was 4.33
(95% CI 2.67–7.02; P  0.001). Furthermore, the asso-
ciations between HBM case status and presence of
osteophytes were also strong, although smaller in mag-
nitude, with an2-fold increase in the prevalence of any
osteophyte and any moderate osteophyte in HBM cases
compared with controls.
When we further adjusted the association be-
tween HBM case status and presence of any entheso-
phyte for the presence of osteophytes, only minimal
attenuation of the association was observed (OR 2.74
[95% CI 1.78–4.21], P 0.001). Similarly, no substantial
attenuation was observed when the association between
HBM case status and presence of any osteophyte was
adjusted for the presence of enthesophytes (OR 1.95
[95% CI 1.24–3.07], P  0.004), implying that osteo-
phytes and enthesophytes are each independently asso-
ciated with HBM (further details available from the
corresponding author upon request).
Sensitivity analyses. Exclusion of individuals with
comorbidities. Relevant comorbidities associated with
enthesophyte formation present in HBM cases included
diabetes (n  26), psoriatic arthritis (n  4), and
hypoparathyroidism (n 2). Excluding these individuals
from the analysis did not alter the associations found
between HBM case status and enthesophytes/
osteophytes (details available from the corresponding
author upon request). Six HBM cases with borderline–
low serum phosphate levels (0.7 mmoles/liter) were
identified; excluding these cases from the analysis did
not alter our findings (details available from the corre-
sponding author upon request). Chondrocalcinosis
within either hip joint was identified in 5.4% of the
radiographs; excluding these radiographs did not mate-
rially affect the associations observed (results not
shown). There were no cases of ankylosing spondylitis,
hyperparathyroidism, acromegaly, or hypophosphatasia
in the HBM group.
Exclusion of DISH cases. The flowing calcifica-
tion and ossification typical of DISH (of which entheso-
phytes are a recognized feature), if present in the lumbar
spine, could potentially lead to misclassification of HBM
case status through artefactual elevation of the mea-
sured BMD (21,22). Therefore, we sought to establish
what proportion of our study population with entheso-
phytes also had DISH affecting the spine, in particular
the L1 vertebra used to define HBM. The widely used
Resnick criteria for DISH (23) were originally applied to
radiographs of the whole spine; however, in our study,
digital spinal radiographs were available only for the
HBM study cases and family controls and were obtained
in the lumbar spine only.
The lumbar spine radiographs of all HBM cases
and family controls with either florid or moderate (grade
2 or 3) enthesophytes (n  75) were reviewed by the
primary observer (SAH) along with a radiologist (MW),
both of whom were blinded with regard to the case/
control status. Definite or possible features of DISH
affecting the L1 vertebra were observed in 19 individuals
(18 HBM cases and 1 family control). Excluding these
individuals resulted in slight attenuation of the OR for
any enthesophyte in HBM cases compared with controls
(OR 2.78 [95% CI 1.81–4.27], P  0.001) and a more
substantial attenuation of the OR for moderate entheso-
phytes (OR 3.10 [95% CI 1.86–5.18], P  0.001).
However, both associations remained strong, suggesting
that the presence of DISH-related changes at L1 does
not explain the HBM–enthesophyte association ob-
served.
We further confirmed this finding by performing
a sensitivity analysis that included only those HBM cases
meeting the index case definition at the hip (total hip Z
score greater than or equal to 3.2; n  100). Strong
associations persisted between HBM case status and the
presence of both enthesophytes and osteophytes, when
compared with the combined control group (details
available from the corresponding author upon request).
Analyses based on HBM cases and controls com-
bined. Hip and L1 BMD according to enthesophyte grade.
To establish whether a dose-response relationship exists
between BMD and the presence of enthesophytes, we
performed an analysis of BMD according to entheso-
phyte grade in the combined population of cases and
controls. A trend toward increasing BMD (unadjusted
mean values) at the L1 vertebra and at the total hip
was observed with increasing enthesophyte grade (Fig-
ures 3A and B). This association persisted at both sites
after full adjustment for age, sex, and BMI (P for trend
 0.001). Interestingly, when we stratified these analyses
by HBM case or control status, we found that the
associations between BMD and enthesophyte grade were
mainly driven by the control group (results not shown),
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Figure 3. Bone mineral density (BMD) at the L1 lumbar vertebra (A)
and at the total hip (B) according to enthesophyte grade in the
combined population of high bone mass (HBM) cases and pooled
controls. Bars show the mean and 95% confidence interval. When
the BMD values for both the right hip and the left hip were avail-
able (n  73), the mean value was used. BMD variables were
standardized according to the scanner type (Hologic for the Ching-
ford and Hertfordshire study controls, mixed Lunar/Hologic for the
HBM cases and family controls). P values for trend were determined
in analyses adjusted for age, sex, and body mass index. The BMD
values at L1 were approximately normally distributed, while the
BMD values at the total hip had 1 extreme outlying value (exclusion of
which did not materially change the results). In A, n  217 HBM cases
and n  426 pooled controls. In B, n  218 HBM cases and n  423
pooled controls.
Figure 4. Mean maximum osteophyte grade per pelvis (scale 0–3) (A),
mean number of osteophyte sites per pelvis (scale 0–6) (B), and mean
total osteophyte score (derived by summing the grades of all osteophytes
on radiographs; scale 0–18) (C) according to enthesophyte grade (absent,
mild, moderate, or florid) in the combined population of high bone mass
cases and controls. Bars show the mean and 95% confidence interval
(absent n 241, mild n 311, moderate n 97, florid n 14). P values
for trend were determined in analyses adjusted for age, sex, and body
mass index.
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with a significant interaction by case–control status
seen at the total hip (interaction P  0.01) but not at L1
(interaction P  0.4).
Enthesophytes versus osteophytes. Having estab-
lished an association between HBM case status and the
presence of both enthesophytes and osteophytes, we
next investigated whether enthesophytes and osteo-
phytes were associated irrespective of case status. As
shown in Figure 4A, in the study population overall, the
enthesophyte grade was positively associated with the
maximum osteophyte grade. Positive associations were
also observed between the enthesophyte grade and the
number of osteophyte sites per pelvis (Figure 4B), as
well as between the enthesophyte grade and the total
osteophyte score (Figure 4C).
Regression analyses were performed to examine
the associations between enthesophytes and osteo-
phytes, in both unadjusted analyses and analyses fully
adjusted for age, sex, and BMI (results available from
the corresponding author upon request). The fully ad-
justed OR for the presence (versus absence) of any
enthesophyte per unit increase in the highest osteophyte
grade was 1.88 (95% CI 1.46–2.43, P 0.001). Similarly,
there was a 3-fold increase in the odds of observing
moderate enthesophytes per unit increase in osteophyte
grade (OR 2.99 [95% CI 2.19–4.07], P  0.001). For
each unit increase in enthesophyte grade, the odds of
any osteophyte being present were increased 2-fold
(OR 2.31 [95% CI 1.68–3.16], P  0.001). Similarly, the
odds of observing any moderate osteophyte per unit
increase in enthesophyte grade were increased 2-fold
(OR 2.49 [95% CI 1.89–3.29], P  0.001).
These associations were then examined sepa-
rately in HBM cases and controls to investigate whether
the relationship between enthesophytes and osteophytes
differed according to HBM status. Although point esti-
mates were greater in controls compared with cases, the
interaction P values were all 0.1, suggesting that these
associations were similar in the 2 groups (results avail-
able from the corresponding author upon request).
DISCUSSION
To our knowledge, this is the first study to
evaluate the presence of radiographic enthesophytes in a
population of individuals with extremely high bone mass.
Consistent with our prior hypothesis, we observed a
higher prevalence of pelvic enthesophytes among HBM
cases compared with controls. Moreover, BMD values in
both the hip and lumbar spine, as assessed by DXA,
increased with increasing severity of enthesophytes. Fur-
thermore, we confirmed the observation made in ar-
chaeologic studies of an association between the pres-
ence of enthesophytes and the presence of osteophytes.
Other investigators previously labeled individuals with
this combination of features as “bone-formers” (3).
It has been reported that individuals with DISH
may have increased BMD at several sites, including the
distal radius and lumbar spine/hip (24,25). This finding,
rather than representing a true increase in BMD, could
be attributed to ossified ligaments within the DXA field,
leading to artefactual increases in measured BMD (21).
We therefore performed a sensitivity analysis that ex-
cluded individuals whose pelvic radiographs showed
moderate or florid enthesophytes and who also had
evidence of DISH-like changes affecting the L1 vertebra
(used to define HBM case status). The overall associa-
tion between HBM and enthesophytes, although slightly
attenuated, remained robust, suggesting that artefactu-
ally increased lumbar BMD measurements due to DISH
do not explain our findings in the majority of cases.
Similarly, the positive association we observed between
hip BMD and enthesophyte grade could not be ex-
plained by the presence of DISH.
OA features such as osteophytes and subchondral
sclerosis within the DXA field could potentially lead to
misclassification of HBM case status. Evidence from the
published literature suggests that whereas lumbar spine
OA contributes to artefactual elevation of the BMD, hip
OA has only a minimal influence on the measured hip
BMD on DXA (26). For this reason, the L1 vertebra was
included in our definition of HBM, since the L1 Z score
was not associated with the severity of lumbar OA
previously assessed on DXA images (16). In addition,
the fact that strong associations between HBM and both
enthesophytes and osteophytes persisted in analyses
restricted to the group of HBM cases defined by high
BMD at the hip suggests that misclassification due to the
presence of lumbar spine OA does not explain our
findings.
Osteophytes and enthesophytes share several
common features. For example, endochondral ossifica-
tion has been shown to be involved in the formation of
osteophytes and some enthesophytes (5,27,28). Further-
more, although the precise triggers for the formation of
osteophytes and enthesophytes remain unclear, mechan-
ical stimuli are likely to play a role (27–29). Animal
models have shown that osteophyte formation may be
induced by altered joint mechanics (e.g., following de-
stabilization of the medial meniscus [30]), and osteo-
phyte formation at specific sites within human knee
joints has been related to biomechanical factors such as
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varus malalignment (31). Similarly, observations indi-
cating that enthesophytes develop in the direction of pull
of the relevant tendon or ligament (3) and may develop
in response to repetitive strain (3,5) support a role for
mechanical stress in the formation of enthesophytes.
Theoretically, the observed association between
HBM and osteophytosis could have arisen either from
altered joint loading secondary to increased bone mass
or as a result of an increased bone-formation response to
a given load. However, in the case of enthesophytes,
altered bone mechanoresponsiveness, rather than al-
tered bone loading per se, is presumably responsible.
Taken together, these findings suggest that altered bone
responsiveness may underlie the apparent triad of osteo-
phytosis, enthesophyte formation, and increased bone
mass that we observed. HBM is associated not only with
an increased risk of osteophytosis, but also with clinical
end points related to OA, such as hip replacement (32).
Therefore, it is tempting to speculate that the tendency
toward excess bone formation associated with this triad
contributes to the pathogenesis of certain subtypes of
OA.
Plausible biologic explanations for the proposed
increased bony proliferative response in these individu-
als include alterations in growth factor expression (27),
which are presumably related to genetic factors (3).
Although the genetic basis for HBM in the majority of
our cases is unknown and is the subject of ongoing
studies, a genome-wide association study in this HBM
population has shown overrepresentation of single-
nucleotide polymorphisms known to be associated with
BMD in the wider population, including loci in Wnt
pathway/endochondral ossification genes (33).
The canonical Wnt signaling pathway is known to
play a key role in the osteoblast response of bone to
mechanical loading (34), and genetic mutations activat-
ing this pathway result in an HBM phenotype (35).
Increased osteogenic activity, arising from up-regulation
of Wnt signaling, could theoretically lead to both in-
creased BMD and a propensity to form enthesophytes/
osteophytes in response to normal or abnormal mechan-
ical strains (analogous to the increased osteogenic
responsiveness seen in mice heterozygous for LRP5-
activating mutations [36]). Interestingly, reduced levels
of Dkk-1 (a Wnt pathway inhibitor) have been associ-
ated with the radiographic severity of both DISH (37)
and knee OA (38,39), and polymorphisms within the
Wnt pathway have also been linked to the risk of OA in
genetic studies (40,41).
This study focused on a population with the
rare HBM phenotype. It is possible that OA in this
group may not be representative of OA in the general
population. However, given the BMD–enthesophyte
and osteophyte–enthesophyte associations observed
when cases and controls were combined, it is tempting
to speculate that these relationships may hold true for
OA more generally, or at least for certain subtypes of
the disease. One proposed phenotypic classification of
OA is based on the local bony response, distinguishing
“hypertrophic” OA, characterized by osteophytes/sclerosis,
from “atrophic” forms of the disease, lacking bony fea-
tures (42–44). Our study suggests that the presence of
radiographic enthesophytes, in addition to osteophytes,
might help to define a subtype of OA in which a bone-
formation response predominates. Alternatively, it has
been proposed that systemic enthesopathy-related OA
should be considered as a specific subphenotype in its
own right, since it has been postulated that in some
cases, ligament/tendon changes may play a primary role
in initiating the OA process (45).
Our study has several limitations. We did not
attempt to examine associations between enthesophytes
and clinical symptoms such as hip pain, or other radio-
graphic OA features such as joint space narrowing.
Our methods for grading radiographic pelvic entheso-
phytes were subjective, because of the absence of any
established grading method (although there have been
2 previous small studies in which a semiquantitative
scoring system was used [46,47]). The fact that osteo-
phytes and enthesophytes were graded by a single ob-
server in one sitting raises the possibility that the
presence of osteophytes may have prompted a more
thorough search for enthesophytes, and vice versa. Our
method has also not been validated against direct exam-
ination of skeletons, arguably the most definitive
method for assessing enthesophytes (4); a radiographic
approach is likely to be less sensitive.
Another limitation is the relatively high number
of incomplete control radiographs that were excluded.
However, because the controls excluded for this reason
tended to be younger and more often female, this
would, if anything, bias our results toward the null by
increasing the prevalence of enthesophytes within the
control group. Another issue (in common with direct
examination of skeletons [27]) is that some osteophytes,
particularly around the acetabulum, might have been
more accurately termed enthesophytes.
Finally, some additional potential confounders,
including smoking, past and present use of steroids,
and alcohol intake, were available at the time of the
radiographic evaluations in the HBM cases and family
controls only, and therefore could not be adjusted for in
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the main analysis. However, adjusting for these variables
in analyses restricted to the HBM study population did
not attenuate the associations between HBM, entheso-
phytes, and osteophytes. Another potential confounder
was physical activity, for which data were not available in
a consistent format across studies.
In conclusion, our results have demonstrated an
increased prevalence of radiographic pelvic entheso-
phytes in a population of individuals with extreme
HBM. This group is also known to have an increased
prevalence of radiographic hip OA, characterized by
osteophytes, and we have further shown that the pres-
ence of osteophytes and the presence of enthesophytes is
associated in these individuals. We speculate that the
triad of osteophytosis, enthesophyte formation, and in-
creased bone mass may identify a subtype of OA pri-
marily caused by increased bone formation. Entheso-
phytes might be usefully added to existing definitions of
hypertrophic OA in order to identify this particular
phenotype. It is hoped that exome sequencing of this
unique HBM population, which is currently under way,
may provide new insights into the molecular mecha-
nisms regulating these processes.
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